Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Interest & Investment Income (2016 - 2026)

Avanos Medical's Interest & Investment Income history spans 13 years, with the latest figure at $600000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 25.0% to $600000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 37.25% decrease, with the full-year FY2025 number at $3.2 million, down 37.25% from a year prior.
  • Interest & Investment Income hit $600000.0 in Q4 2025 for Avanos Medical, up from $500000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for AVNS hit a ceiling of $3.0 million in Q2 2024 and a floor of $200000.0 in Q3 2021.
  • Historically, Interest & Investment Income has averaged $787500.0 across 5 years, with a median of $600000.0 in 2024.
  • Biggest five-year swings in Interest & Investment Income: surged 500.0% in 2024 and later crashed 80.0% in 2025.
  • Tracing AVNS's Interest & Investment Income over 5 years: stood at $200000.0 in 2021, then soared by 250.0% to $700000.0 in 2022, then soared by 42.86% to $1.0 million in 2023, then decreased by 20.0% to $800000.0 in 2024, then fell by 25.0% to $600000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for AVNS at $600000.0 in Q4 2025, $500000.0 in Q3 2025, and $600000.0 in Q2 2025.